Showing 2711-2720 of 18644 results for "".
Integrating New Therapies Into Healthcare
https://reachmd.com/programs/cme/integrating-new-therapies-into-healthcare/35553/Don’t miss this opportunity to learn the latest in new and emerging hemophilia therapies and optimize your patient care strategies.Epilepsy: Beyond Seizure Impact
https://reachmd.com/programs/cme/epilepsy-beyond-seizure-impact/35794/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
https://reachmd.com/programs/cme/considering-the-promise-of-new-and-emerging-treatments-for-hemophilia-the-need-for-iti/35551/Don’t miss this opportunity to learn the latest in new and emerging hemophilia therapies and optimize your patient care strategies.Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
https://reachmd.com/programs/cme/why-are-the-fetus-and-placenta-not-rejected-by-the-mother-new-insights-into-maternal-anti-fetal-rejection/13912/Have you thought about the fetus and placenta as transplants? Tune in to hear experts break down the mechanisms of maternal anti-fetal rejection.PROMs in Clinical Practice: Impacting Treatment Decisions
https://reachmd.com/programs/cme/proms-in-clinical-practice-impacting-treatment-decisions/33243/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.Patient-Reported Outcome Measures (PROMs): Valuable Insights Into the Lived Experience of PAH
https://reachmd.com/programs/cme/patient-reported-outcome-measures-proms-valuable-insights-into-the-lived-experience-of-pah/33240/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.Women in Aesthetics: Fairyal Day
https://modernaesthetics.com/topics/practice-development/women-in-aesthetics-fairyal-day/48886/Get to know Fairyal Day, Founder of Med Talent, Global Medical Search, an executive search firm specializing in the medical aesthetics, dermatology, dental, and pharmaceutical industriesAAT C-Terminal Peptides Show Independent Prognostic Value in Early-Stage NSCLC
https://reachmd.com/programs/project-oncology/aat-c-terminal-peptides-show-independent-prognostic-value-in-early-stage-nsclc/39032/Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
https://reachmd.com/programs/project-oncology/prognostic-value-of-red-cell-distribution-width-at-ruxolitinib-initiation-in-myelofibrosis/37207/Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
https://reachmd.com/programs/neurofrontiers/vitamin-d3-effects-on-inflammatory-and-oxidative-biomarkers-in-ms/54233/